Boston Scientific (BSX) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 21.6% | 25.4% | 24.2% | 23.5% | 18.6% | 23.1% | ||
| Changes by years, y/y, % | +0pp | +4pp | -1pp | -1pp | -5pp | +4.1% | |||
Boston Scientific. EBITDA margin, %
Boston Scientific. EBITDA margin, changes, pp
Boston Scientific (BSX) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 26.1% | 27.0% | 27.0% | 18.1% | 20.6% | 23.1% | |
| Changes by years, y/y, % | +1pp | +7pp | +2pp | -5pp | -5pp | |||
| Changes by quarters, q/q, % | +3pp | +1pp | 0pp | -9pp | +3pp | |||